Breast cancer genomic test could spare millions from chemotherapy
“The company developing the drug, #RevolutionMedicines, presented results on May 31, 2026, from its Phase 3 clinical trial of 500 patients with metastatic #PancreaticCancer who had received prior treatment.
Compared to standard #chemotherapy, #daraxonrasib nearly doubled overall survival from 6.7 months to 13.2 months after diagnosis. Overall, daraxonrasib reduced the risk of death for metastatic pancreatic cancer patients by 60%.”
https://www.sciencealert.com/a-breakthrough-drug-just-achieved-the-impossible-for-pancreatic-cancer
#beverlylanderson #chemotherapy #chemowarrior #chemo #chemosideeffects #chemohair #ovariancancer #cancersucks #fuckcancer #ovariancancerwarrior #cancer #cancersymptoms #cancerprevention #cancerawareness #cancerjourney #atealjouney #gofundme #medicalbills #mutualaid
DNA research on #BreastCancer #Chemotherapy giving new treatment options.
“Millions of people with breast cancer could safely avoid chemotherapy as scientists have developed a DNA test that can distinguish between patients who are likely to benefit from the treatment and those who are not, according to the results of a trial.
The international study found that more than two-thirds of its participants could be spared the side of effects of chemotherapy and be treated with hormone therapy alone.”
neat_news
Xamanismo Coletivo
All Scientifical
Beverly L. Anderson
Kirsty